9 Meters Biopharma (NMTR) Receives Orphan Drug Designation for NM-003, Proprietary Long-Acting GLP-2, for Prevention of aGvHD

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/26/2026

1. ON
2. SYNA
3. SPY
4. MU
5. VEON
6. AAPL
7. DRI
8. NKE
9. USO
10. NVDA

Go back to 9 Meters Biopharma (NMTR) Receives Orphan Drug Designation for NM-003, Proprietary Long-Acting GLP-2, for Prevention of aGvHD

UPDATE: 9 Meters Biopharma (NMTR) Prices 46.154M Share Common Offering at $0.65/Sh

December 11, 2020 8:35 AM EST

(Updated - December 11, 2020 8:35 AM EST)

9 Meters Biopharma, Inc. (NASDAQ: NMTR) announced today the pricing of an underwritten public offering of 46,153,847 shares of its common stock at a price to the public of $0.65 per share. In addition, the Company has granted the underwriters a 30-day... More